Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma-Reference-Cited by-同舟云学术

Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma

Published:2017 Issue:6 Volume:31 Page:538
ISSN:1011-8942
Container-title:Korean Journal of Ophthalmology
language:en
Short-container-title:Korean J Ophthalmol

Author:

Ha Jun Young¹,Lee Tae Hee¹,Sung Mi Sun¹,Park Sang Woo¹²

Affiliation:

1. Department of Ophthalmology and Research Institute of Medical Sciences, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.

2. Center for Creative Biomedical Scientists, Chonnam National University, Gwangju, Korea.

Publisher

Korean Ophthalmological Society

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3341/kjo.2017.0017

Reference21 articles.

1. Neovascular Glaucoma: Etiology, Diagnosis and Prognosis

2. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma1 1The authors do not have any proprietary or financial interest in any products or devices discussed in this study.

3. Retinopathy Risk Factor Regression After Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

4. Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

5. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of anti-vascular endothelial growth factor combined with Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma: a systematic review and meta-analysis;Frontiers in Medicine;2024-07-31

2. Advances and Challenges in Wearable Glaucoma Diagnostics and Therapeutics;Bioengineering;2024-01-30

3. Anti-vascular endothelial growth factor for neovascular glaucoma;Cochrane Database of Systematic Reviews;2023-04-03

4. A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment;Medicina;2022-12-18

5. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment;Borneo Journal of Pharmacy;2022-08-31